MY ACCOUNT | NEWSLETTER |

Enhancing Capacity for Infectious Disease Research

New university findings highlight potential implications for dogs, cancer, and veterinary practice.


Select Building the Veterinary College of the Future Enhancing Capacity for Infectious Disease Research Training the Next Generation of Veterinary Clinician Scientists Strengthening "One Health" Approach to Tackling Cancer Before a deadly disease makes headlines, it often starts quietly—in animals.

Enhancing Capacity for Infectious Disease Research | College of Veterinary Medicine at MSU Support the College of Veterinary Medicine Search Tool Uncommon Will.

COVID-19, avian influenza, and Ebola are just a few examples of zoonotic diseases—illnesses that originate in animals and cross over to people.

As human and animal environments become increasingly interconnected through global trade, urban development, and climate pressures, these cross-species threats are becoming more common.

And beyond these emerging zoonotic threats, we continue to combat challenges such as brucellosis in livestock and antimicrobial-resistant tuberculosis.

That’s why pandemic prevention doesn’t start in human hospitals.

It starts in places like the Michigan State University Veterinary Diagnostic Laboratory.

The MSU VDL is one of the most advanced labs in the country.

It plays a critical role in identifying emerging diseases early—often in animal populations, before they ever affect people.

This is how outbreaks are detected, tracked, and contained before they become global crises.

But detection is just the first step.

The report adds to ongoing university-led research relevant to veterinary medicine, animal health, and clinical decision-making.

Source university website: Michigan State University College of Veterinary Medicine

https://cvm.msu.edu/friends-alumni/uncommon-will-far-better-world/enhancing-capacity-for-infectious-disease-research

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Effect of dietary Ca:P ratio on ionized calcium and calcium homeostasis in cats with early-stage chronic kidney disease.

Like0
Dislike0

Steroidal response following intravenous administration of long-term frozen tetracosactide acetate in healthy Beagles.

Like0
Dislike0

An evidence-based algorithm for parenteral antimicrobial treatment of neonatal calf diarrhea: A blinded randomized controlled trial.

Like0
Dislike0

FDA Approves First Single-Dose Generic Treatment for Influenza

Like0
Dislike0

Pilot Study for a New Quasiorganelle Therapy in Dogs with Histiocytic Sarcoma

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top